J. Hoofnagle

发表

Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports

E. Björnsson, J. Hoofnagle, 2016, Hepatology.

Reactivation of chronic type B hepatitis presenting as acute viral hepatitis.

J. Hoofnagle, G. Davis, 1985, Annals of internal medicine.

Overweight, obesity, and health risk.

Leonard H. Epstein, F. X. Pi-Sunyer, James E. Everhart, 2000, Archives of internal medicine.

LiverTox: A website on drug‐induced liver injury

J. Serrano, J. Hoofnagle, J. Knoben, 2013, Hepatology.

Course and outcome of hepatitis C

J. Hoofnagle, 2002, Hepatology.

Fulminant hepatic failure: Summary of a workshop

J. Hoofnagle, C. Shapiro, R. Carithers, 1995, Hepatology.

Important elements for the diagnosis of drug-induced liver injury.

J. Hoofnagle, J. McHutchison, Jay H Hoofnagle, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Psychiatric complications of long-term interferon alfa therapy.

J. Hoofnagle, D. Jones, M. Peters, 1987, Archives of internal medicine.

Gallstones and Laparoscopic Cholecystectomy

John V. White, Frank A. Hamilton, Janet D. Elashoff, 1993 .

Training the gastroenterologist of the future: the Gastroenterology Core Curriculum.

D. Brenner, W. Heizer, K. Hall, 2003, Gastroenterology.

Liver injury from herbal and dietary supplements

J. Serrano, E. Björnsson, J. Hoofnagle, 2017, Hepatology.

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.

N. Chalasani, J. Hoofnagle, D. Kleiner, 2009, Contemporary clinical trials.

B Virus Polymerase Cellular Immune Responses to the Hepatitis

J. Sidney, A. Sette, J. Hoofnagle, 2013 .

Cellular Immune Responses to the Hepatitis B Virus Polymerase12

J. Sidney, A. Sette, J. Hoofnagle, 2004, The Journal of Immunology.

Cellular Immune Responses to the Hepatitis B Virus Polymerase 1 , 2

J. Sidney, A. Sette, J. Hoofnagle, 2004 .

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.

F. Chisari, J. Hoofnagle, B. Rehermann, 1996, The Journal of clinical investigation.

Increased caffeine consumption is associated with reduced hepatic fibrosis

J. Hoofnagle, J. Everhart, D. Kleiner, 2010, Hepatology.

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

K. Ishak, J. Hoofnagle, Z. Goodman, 1991, Hepatology.

The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.

J. Hoofnagle, M. Houghton, Q. Choo, 1991, The American journal of gastroenterology.

Hepatitis C in asymptomatic blood donors

J. Hoofnagle, D. Herion, H. Alter, 1997, Hepatology.

Recurrent and new hepatitis C virus infection after liver transplantation

R. Wiesner, J. Hoofnagle, H. Eng, 1999, Hepatology.

Donor age and outcome of liver transplantation

J. Hoofnagle, K. Detre, J. Everhart, 1996, Hepatology.

The interferon sensitivity determining region: All hepatitis C virus isolates are not the same

J. Hoofnagle, D. Herion, 1997, Hepatology.

Genotypic analysis of hepatitis C virus in American patients

J. Hoofnagle, R. Sallie, G. Maertens, 1994, Hepatology.

National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002

J. Hoofnagle, L. Seeff, 2002, Hepatology.

Management of hepatitis C: current and future perspectives.

J. Hoofnagle, 1999, Journal of hepatology.

Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

J. Hoofnagle, A. D. Di Bisceglie, S. Feinstone, 1991, The Journal of clinical investigation.

Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C

J. Hoofnagle, D. Herion, H. Blum, 2000, Hepatology.

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.

J. Hoofnagle, T. Liang, D. Kleiner, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD).

J. Hoofnagle, S. Belle, J. Lake, 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.

J. Hoofnagle, J. Metcalf, R. Davey, 1999, Journal of Infectious Diseases.

Hepatitis G Virus and Human Immunodeficiency Virus Coinfection: Response to Interferon-α Therapy

J. Hoofnagle, J. Metcalf, R. Davey, 1999 .

Reactivation of hepatitis B

J. Hoofnagle, Jay H. Hoofnagle, 2009, Hepatology.

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?

A. Lok, J. Hoofnagle, N. Terrault, 2015, Hepatology.

Reactivation of Hepatitis B

J. Hoofnagle, 2009 .

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

J. Hoofnagle, L. Seeff, H. Zimmerman, 1978, The New England journal of medicine.

Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.

J. Goedert, J. Hoofnagle, R. Biggar, 1987, The New England journal of medicine.

New therapies for hepatitis C

J. Hoofnagle, A. Modi, 2007, Hepatology.

Antibody to hepatitis-B-virus core in man.

J. Hoofnagle, L. Barker, R. Gerety, 1973, Lancet.

Serologic Diagnosis of Acute and Chronic Viral Hepatitis

J. Hoofnagle, A. D. Di Bisceglie, J. Hoofnagle, 1991, Seminars in liver disease.

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

B. Neuschwander‐Tetri, N. Chalasani, J. Hoofnagle, 2010, The New England journal of medicine.

Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization.

J. Hoofnagle, F. Negro, J. Gerin, 1989, Hepatology.

Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C.

J. Hoofnagle, K. Reddy, M. Ghany, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity

J. Hoofnagle, T. Liang, D. Kleiner, 2017, Hepatology.

Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

E A Jones, J. Hoofnagle, S. James, 1983, The Journal of clinical investigation.

In vitro immune responses to hepatitis B surface antigen (pre-S2 and S) following remote infection by hepatitis B virus in humans

J. Hoofnagle, L. Seeff, J. Gerin, 1989, Journal of Clinical Immunology.

In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.

J. Hoofnagle, J. Gerin, R. Ellis, 1990, The Journal of infectious diseases.

In vitro synthesis and immunoregulation of antibody to hepatitis B surface antigen in man

J. Hoofnagle, R. Hanson, E. Jones, 1986 .

Immune effects of α-interferon in chronic liver disease

J. Hoofnagle, M. Peters, M. Avigan, 1986 .

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis

J. Hoofnagle, M. Peters, R. Hanson, 1986, Hepatology.

Type B Hepatitis: Virology, Serology and Clinical Course

J. Hoofnagle, 1981, Seminars in liver disease.

Natural History , Treatment , and Prevention of Hepatitis C Moderator :

J. Hoofnagle, L. Seeff, B. Rehermann, 2000 .

Hepatitis B virus infection in chimpanzees: titration of subtypes.

R. Purcell, J. Hoofnagle, L. Barker, 1975, The Journal of infectious diseases.

Stability of HCV‐RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers

A. E. Yeo, J. Hoofnagle, D. Kleiner, 2001, Journal of viral hepatitis.

Combination Therapy with Famciclovir and Interferon-α for the Treatment of Chronic Hepatitis B

J. Hoofnagle, S. Straus, D. Lau, 1998 .

Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis

R. Branch, P. Arns, J. Hoofnagle, 1997, Clinical pharmacology and therapeutics.

Ribavirin as Therapy for Chronic Hepatitis C

H. Conjeevaram, J. Hoofnagle, C. Yurdaydın, 1995, Annals of Internal Medicine.

Thymosin: An Innovative Approach to the Treatment of Chronic Hepatitis B

J. Hoofnagle, D. Shafritz, M. Mutchnick, 1992 .

Thymosin treatment of chronic hepatitis B: A placebo‐controlled pilot trial

J. Hoofnagle, D. Shafritz, H. Appelman, 1991, Hepatology.

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B

S. Banks, J. Hoofnagle, A. D. Di Bisceglie, 1991, Hepatology.

A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.

S. Banks, J. Hoofnagle, Z. Goodman, 1990, Journal of hepatology.

Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis

K. Ishak, J. Hoofnagle, G. Minuk, 1982, Hepatology.

Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.

J. Hoofnagle, T. Liang, M. Ghany, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Experimental infection of chimpanzees with hepatitis A virus.

R. Purcell, J. Hoofnagle, L. Barker, 1975, The Journal of infectious diseases.

Therapy for hepatitis C--the costs of success.

J. Hoofnagle, A. Sherker, 2014, The New England journal of medicine.

From non-A, non-B hepatitis to hepatitis C virus cure.

J. Hoofnagle, J. Pawlotsky, S. Zeuzem, 2015, Journal of hepatology.

Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B

R. Fontana, J. Hoofnagle, A. Wahed, 2021, GastroHep.

Hepatitis C: Down but Not Out

J. Hoofnagle, A. Sherker, 2017, Annals of Internal Medicine.

Hepatitis C and renal disease: an update.

J. Hoofnagle, C. Stehman-Breen, C. Meyers, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Therapy for acute hepatitis C.

J. Hoofnagle, 2001, The New England journal of medicine.

II Therapy of chronic hepatitis C

J. Hoofnagle, J. McHutchison, J. Mchutchison, 2000 .

The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes

J. Hoofnagle, B. Rehermann, R. Loomba, 2011, Alimentary pharmacology & therapeutics.

Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.

Kathryn J Fowler, O. Cummings, C. Sirlin, 2020, Gastroenterology.

Drug-induced liver injury: Icelandic lessons.

J. Hoofnagle, V. Navarro, 2013, Gastroenterology.

Duloxetine hepatotoxicity: a case‐series from the drug‐induced liver injury network

R. Fontana, H. Bonkovsky, N. Chalasani, 2010, Alimentary pharmacology & therapeutics.

Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.

J. Hoofnagle, B. Borg, 2005, The New England journal of medicine.

Weight change and obesity after liver transplantation: incidence and risk factors.

R. Wiesner, J. Hoofnagle, J. Everhart, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

B. Garra, S. Steinberg, J. Hoofnagle, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reports from the NIH DDDN. Research support from the Division of Digestive Diseases and Nutrition.

J. Hoofnagle, S. Kalser, 1990, Gastroenterology.

Precipitin system detected in sera from patients with non‐A, non‐B hepatitis

J. Hoofnagle, 1981, Journal of medical virology.

Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis

B. Neuschwander‐Tetri, J. Hoofnagle, D. Kleiner, 2013, Alimentary pharmacology & therapeutics.

Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

J. Hoofnagle, H. Brewer, E. Schaefer, 1985, Gastroenterology.

Histopathologic changes associated with fialuridine hepatotoxicity.

M. Gaffey, J. Hoofnagle, D. Kleiner, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

B. Weintraub, J. Hoofnagle, A. Bisceglie, 1992, Gastroenterology.

Side Effects of Alpha Interferon

J. Hoofnagle, P. Renault, J. Hoofnagle, 1989, Seminars in liver disease.

Garcinia Cambogia, Either Alone or in Combination with Green Tea Causes Moderate to Severe Liver Injury.

Jiezhun Gu, H. Barnhart, R. Fontana, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

FXR Agonists as Therapy for Liver Disease

J. Hoofnagle, 2020, Hepatology.

Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.

Christopher J. N. Kigongo, Kathryn J Fowler, O. Cummings, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Elevations in serum alpha‐fetoprotein levels in patients with chronic hepatitis B

J. Hoofnagle, A. D. Di Bisceglie, 1989, Cancer.

Reye's syndrome-like illness in a patient receiving amiodarone.

J. Hoofnagle, F. Mullick, D. Jones, 1988, The American journal of gastroenterology.

Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells.

J. Hoofnagle, R. Kahn, P. Holland, 1978, The New England journal of medicine.

Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers

J. Hoofnagle, A. Bisceglie, J. Waggoner, 1987 .

Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1987, Gastroenterology.

Conditions associated with hepatocellular carcinoma.

J. Hoofnagle, M. Lisker‐Melman, P. Martín, 1989, The Medical clinics of North America.

Significance of hepatitis B core antigen in the liver in patients with chronic hepatitis B and its relation to hepatitis B virus DNA

J. Hoofnagle, A. Dibisceglie, Choong Kee Park, 1990, Journal of gastroenterology and hepatology.

Primary Biliary Cirrhosis: A Model Autoimmune Disease

J. Hoofnagle, S. James, E. Jones, 1983 .

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

J. Hoofnagle, L. Seeff, 2002, Gastroenterology.

On the role of sexual behavior in the spread of hepatitis B infection.

J. Hoofnagle, W. Szmuness, A. Prince, 1975, Annals of internal medicine.

Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century

J. Hoofnagle, R. Wells, R. Sokol, 2018, Hepatology.

Autoimmune hepatitis: The investigational and clinical challenges

J. Hoofnagle, A. Czaja, I. Mcfarlane, 2000, Hepatology.

Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C.

J. Hoofnagle, B. Bacon, D. Kleiner, 1994, Journal of Hepatology.

Hepatitis C Virus Infection T Cells in Chronic + Virus-Specific CD8 Impaired Effector Function of Hepatitis C

J. Hoofnagle, T. Liang, H. Greenberg, 2002 .

Lymphokines and bile secretion in the rat.

J. Hoofnagle, D. Jones, C. Dinarello, 2008, Liver.

Measurements of iron status in patients with chronic hepatitis.

J. Hoofnagle, B. Bacon, A. Bisceglie, 1992, Gastroenterology.

Lipoprotein abnormalities in primary biliary cirrhosis

J. Hoofnagle, H. Brewer, E. Schaefer, 1985 .

Treatment of Chronic Hepatitis C in Non-Responders

J. Hoofnagle, 2004 .

Optimal therapy of hepatitis C

J. Hoofnagle, A. D. Di Bisceglie, 2002, Hepatology.

Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1989, Gastroenterology.

Complementary and alternative medicine in chronic liver disease

J. Hoofnagle, B. Bacon, L. Seeff, 2001, Hepatology.

Pilot study of interferon gamma for chronic hepatitis C.

J. Hoofnagle, M. Ghany, A. Soza, 2005, Journal of hepatology.

HIV Through the Looking Glass: Insights Derived From Hepatitis B

J. Hoofnagle, D. Kleiner, A. Soza, 2015, Journal of acquired immune deficiency syndromes.

Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

J. Hoofnagle, C. Hallahan, C. Meschievitz, 1988 .

Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers

K. Ishak, J. Hoofnagle, L. Seeff, 1987, Journal of medical virology.

Prevention of type B hepatitis

J. Hoofnagle, 1979 .

Serologic markers of hepatitis B virus infection.

J. Hoofnagle, D. Schafer, J. H. Hoofnagle, 1986, Seminars in liver disease.

Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.

J. Hoofnagle, J. Everhart, H. Alter, 1990, Annals of internal medicine.

Management of hepatitis C: A national survey of gastroenterologists and hepatologists

J. Hoofnagle, M. Stolar, J. Everhart, 1997, Hepatology.

Dose‐finding study of interferon alfa‐n3 in hepatitis

J. Hoofnagle, J. Everhart, 1997 .

Randomized trial of chlorambucil for primary biliary cirrhosis.

J. Hoofnagle, G. Campbell, G. Davis, 1986, Gastroenterology.

Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network

Jiezhun Gu, H. Barnhart, R. Fontana, 2014, Hepatology.

Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study

Jiezhun Gu, R. Fontana, J. Hoofnagle, 2022, The American journal of gastroenterology.

Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B – author's reply

J. Hoofnagle, 2012 .

Vitamin E deficiency in adults with chronic liver disease.

J. Hoofnagle, R. Sokol, E. Jones, 1985, The American journal of clinical nutrition.

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

P. Rosenthal, N. Chalasani, J. Hoofnagle, 2011, JAMA.

Hepatic methionine adenosyltransferase deficiency in a 31-year-old man.

K. Ishak, J. Hoofnagle, W. Gahl, 1987, American journal of human genetics.

Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: Clinical significance and correlation with serological and biochemical markers

J. Hoofnagle, S. Kaneko, B. Baker, 1991, Hepatology.

Sjögren's syndrome in patients with primary biliary cirrhosis

J. Hoofnagle, H. Moutsopoulos, P. Fox, 1990, Hepatology.

Transmission of viral hepatitis, type B, by plasma derivatives.

J. Hoofnagle, L. Barker, 1974, Developments in biological standardization.

Antibody to the Hepatitis B Surface Antigen in Immune Serum Globulin

J. Hoofnagle, L. Barker, R. Gerety, 2003, Transfusion.

Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group.

J. Hoofnagle, L. Seeff, H. Zimmerman, 1979, Annals of internal medicine.

Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa.

H. Conjeevaram, J. Hoofnagle, M. Fried, 1995, Gastroenterology.

Detection and quantitation of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system.

J. Hoofnagle, J. Silver, A. D. Di Bisceglie, 1994, Journal of virological methods.

Circulating activated B cells in primary biliary cirrhosis

J. Hoofnagle, S. James, E. Jones, 1985, Journal of Clinical Immunology.

A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000.

Morton B. Brown, P. Rosenthal, J. Hoofnagle, 2006, The Journal of pediatrics.

Immunoprophylaxis of viral hepatitis.

J. Hoofnagle, L. Seeff, 1979, Gastroenterology.

Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon‐α

J. Hoofnagle, A. McCullough, K. Mullen, 1994, Hepatology.

Long‐term follow‐up of patients with chronic hepatitis C treated with α‐interferon

J. Hoofnagle, A. D. Di Bisceglie, M. Shindo, 1992, Hepatology.

Anti-complement receptors in PBC in the clearance of complement coated cells in primary biliary cirrhosis

J. Hoofnagle, M. Frank, G. Minuk, 2006 .

Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.

J. Hoofnagle, M. Frank, G. Minuk, 1986, Gut.

Therapy of acute and chronic viral hepatitis.

J. Hoofnagle, 1994, Advances in internal medicine.

Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations.

J. Hoofnagle, 1990, Journal of hepatology.

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

J. Hoofnagle, T. Liang, G. Ahlenstiel, 2010, Gastroenterology.

Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes

J. Hoofnagle, M. Reitman, Simeon I. Taylor, 2000, Annals of Internal Medicine.

Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

J. Hoofnagle, T. Liang, D. Kleiner, 2009, Alimentary pharmacology & therapeutics.

Screening and outcomes in biliary atresia: Summary of a National Institutes of Health workshop

J. Hoofnagle, R. Superina, R. Sokol, 2007, Hepatology.

Action plan for liver disease research

J. Hoofnagle, 2004, Hepatology.

Epidemiologic research and the action plan for liver disease research.

J. Hoofnagle, J. Everhart, Megan E Miller, 2006, Annals of epidemiology.

The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence

A. Lok, J. Hoofnagle, T. Liang, 2021, Hepatology.

The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.

J. Hoofnagle, A. D. Di Bisceglie, T. Akatsuka, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Hepatitis C Viral RNA and Hepatic Cytokine Expression in Chronic Hepatitis C: Effects of Alpha Interferon Therapy

J. Hoofnagle, A. Dibisceglie, M. Shindo, 1994 .

Changes in hepatitis C virus antigen in liver with antiviral therapy.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1993, Gastroenterology.

Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.

J. Hoofnagle, A. D. Di Bisceglie, S. Feinstone, 1992, Archives of virology. Supplementum.

Therapy of chronic hepatitis C with α‐interferon: The answer? Or more questions?

J. Hoofnagle, A. D. Di Bisceglie, 1991 .

Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C

J. Hoofnagle, A. Bisceglie, P. Fox, 1992 .

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.

J. Hoofnagle, D. Kleiner, M. Gershwin, 2015, American journal of clinical pathology.

Hepatitis B virus infection in the Wiskott-Aldrich syndrome.

J. Hoofnagle, R. Blaese, P. Holland, 1976, The Journal of pediatrics.

Methotrexate therapy of primary biliary cirrhosis: promising but worrisome.

J. Hoofnagle, N. Bergasa, 1991, Gastroenterology.

Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.

J. Hoofnagle, J. Gerin, S. Krugman, 1974, The New England journal of medicine.

Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease.

J. Hoofnagle, R. Varma, S. James, 1986, Gastroenterology.

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

J. Hoofnagle, D. Kleiner, M. Ghany, 2004, Hepatology.

Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

J. Hoofnagle, T. Liang, N. Young, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis

J. Hoofnagle, E. Jones, M. Avigan, 1986, Hepatology.

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.

Jiezhun Gu, R. Fontana, H. Bonkovsky, 2022, Journal of hepatology.

Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon.

J. Hoofnagle, G. Davis, J. Dooley, 1985, Laboratory investigation; a journal of technical methods and pathology.

Durable virological response and functional cure of chronic hepatitis D after long‐term peginterferon therapy

J. Hoofnagle, J. Glenn, D. Kleiner, 2021, Alimentary pharmacology & therapeutics.

Introducing the AASLD President: Adrian Di Bisceglie

J. Hoofnagle, 2014, Hepatology.

Intestinal malabsorption of vitamin E in primary biliary cirrhosis.

J. Hoofnagle, R. Sokol, E. Jones, 1989, Gastroenterology.

4 Acute hepatitis C

J. Hoofnagle, 2000 .

Liver injury is associated with mortality in sickle cell disease

M. Gladwin, J. Nichols, J. Hoofnagle, 2015, Alimentary pharmacology & therapeutics.

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.

J. Hoofnagle, M. Shiffman, T. S. Tralka, 1995, Hepatology.

Antiviral therapy of hepatitis C--present and future.

J. Hoofnagle, A. D. Di Bisceglie, M. Shindo, 1993, Journal of hepatology.

Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis

J. Hoofnagle, J. Waggoner, M. Sjogren, 1987, Hepatology.

Mortality follow‐up of the 1942 epidemic of hepatitis B in the U.S. Army

G. Beebe, J. Hoofnagle, L. Seeff, 1993, Hepatology.

Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus

R. Purcell, K. Ishak, J. Hoofnagle, 1984, Hepatology.

A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus.

R. Purcell, J. Hoofnagle, J. Gerin, 1987, The Journal of infectious diseases.

Treatment of chronic delta hepatitis with recombinant human alpha interferon.

J. Hoofnagle, M. Peters, B. Hoyer, 1987, Progress in clinical and biological research.

Age and liver transplantation: a report of the Liver Transplantation Database.

R. Wiesner, J. Hoofnagle, J. Everhart, 1998, Transplantation.

The National Commission on Digestive Diseases

J. Hoofnagle, 2006, Hepatology.

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—June 10‐12, 2002

J. Hoofnagle, L. Seeff, 2002, Hepatology.

Hepatic veno-occlusive disease in a patient with systemic lupus erythematosus.

J. Hoofnagle, D. Malone, E. Jones, 1984, Arthritis and rheumatism.

Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort.

P. Rosenthal, J. Hoofnagle, S. Ling, 2019, Journal of pediatric gastroenterology and nutrition.

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

William M. Lee, R. Fontana, A. Lok, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Lamivudine for chronic delta hepatitis

J. Hoofnagle, D. Kleiner, P. Schmid, 1999, Hepatology.

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.

J. Hoofnagle, G. Davis, L. Seeff, 2020, Annals of internal medicine.

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase.

R. Miller, J. Hoofnagle, H. Mitsuya, 1989, Gastroenterology.

Scar undone: long-term therapy of hepatitis B

J. Hoofnagle, M. Tana, 2013, The Lancet.

J. Hoofnagle, J. Everhart, 1992, Gastroenterology.

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the national digestive diseases advisory board

J. Hoofnagle, M. Shiffman, T. S. Tralka, 1995, Hepatology.

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

J. Hoofnagle, L. Seeff, 2002, HIV clinical trials.

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.

J. Hoofnagle, A. D. Di Bisceglie, M. Shindo, 1992, Gastroenterology.

Viral hepatitis, type B, in experimental animals.

R. Purcell, J. Hoofnagle, L. Barker, 1975, The American journal of the medical sciences.

Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees.

J. Hoofnagle, L. Barker, J. Markenson, 1975, The Journal of infectious diseases.

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.

J. Hoofnagle, C. Hallahan, C. Meschievitz, 1988, Gastroenterology.

Chronic hepatitis in hemophilia.

J. Hoofnagle, L. Seeff, 1977, Annals of internal medicine.

The prevalence of hepatitis B surface antigen in commercially prepared plasma products.

J. Hoofnagle, L. Barker, J. Thiel, 1976, The Journal of laboratory and clinical medicine.

Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1991, Annals of internal medicine.

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

J W Shih, J. Hoofnagle, R. Kaslow, 1996, The New England journal of medicine.

Chronic type B hepatitis and the “healthy” Hbsag carrier state

J. Hoofnagle, D. Shafritz, H. Popper, 1987, Hepatology.

Classification of chronic hepatitis: Diagnosis, grading and staging

J. Hoofnagle, P. Scheuer, M. Manns, 1994, Hepatology.

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

J. Sarles, P. Rosenthal, H. Conjeevaram, 1998, Gastroenterology.

Progression of fibrosis in chronic hepatitis C.

J. Hoofnagle, T. Liang, D. Kleiner, 2003, Gastroenterology.

Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C.

J. Hoofnagle, P. Fox, M. Fried, 1992, Gastroenterology.

National institutes of health consensus development conference: Management of hepatitis C: 2002

J. Hoofnagle, L. Seeff, 2002, Clinics in liver disease.

Shock wave-induced pancreatic trauma.

J. Hoofnagle, K. Mullen, E. Jones, 1991, The American journal of gastroenterology.

Long‐term therapy of chronic hepatitis B with lamivudine

J. Hoofnagle, T. Liang, D. Kleiner, 2000, Hepatology.

Therapy of Viral Hepatitis

J. Hoofnagle, 1998, Digestion.

Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop

J. Hoofnagle, T. Liang, S. Lemon, 2007, Hepatology.

IgM Antibody to Hepatitis B Core Antigen in Korean Patients with Hepatocellular Carcinoma

J. Hoofnagle, S. Lemon, Jay H. Hoofnagle, 1984, Hepatology.

Use of complementary and alternative medicine in patients with liver disease

J. Hoofnagle, B. Bacon, L. Seeff, 2002, American Journal of Gastroenterology.

Pyoderma gangrenosum associated with primary biliary cirrhosis.

J. Hoofnagle, G. Minuk, J. Fine, 1983, Archives of internal medicine.

Hepatitis B virus infection in the acquired immunodeficiency syndrome.

E. Gelmann, J. Hoofnagle, J. Gerin, 1984, Annals of internal medicine.

Milk thistle and chronic liver disease

J. Hoofnagle, 2005, Hepatology.

Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes

Jiezhun Gu, Jiezhun Gu, N. Chalasani, 2017, Journal of clinical gastroenterology.

The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.

Jiezhun Gu, H. Barnhart, R. Fontana, 2018, Journal of hepatology.

Serological diagnosis of acute viral hepatitis

J. Hoofnagle, L. Seeff, L. Mathiesen, 1985, Digestive Diseases and Sciences.

Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations

William M. Lee, Jiezhun Gu, H. Barnhart, 2013, Hepatology.

Intrahepatic markers of hepatitis delta virus infection: A study by in Situ hybridization

J. Hoofnagle, F. Negro, A. Bisceglie, 1989, Hepatology.

Peroxidase‐anti‐peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis

J. Hoofnagle, J. Waggoner, R. Howard, 1987, Journal of medical virology.

Transmission of non-A, non-B hepatitis.

R. Purcell, J. Hoofnagle, L. Barker, 1977, Annals of internal medicine.

Sustained virologic response to interferon alpha (IFN-α) in chronic hepatitis C is associated with long-term histologic improvement and lack of hepatic HCV RNA

J. Hoofnagle, D. Kleiner, M. Ghany, 1998 .

Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1

J. Hoofnagle, T. Liang, H. Greenberg, 2002, The Journal of Immunology.

Identification and Characterization of Cefazolin-Induced Liver Injury.

Jiezhun Gu, J. Hoofnagle, D. Rockey, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Changes in Quality of Life After Liver Transplantation Among Adults

J. Hoofnagle, S. Belle, J. Lake, 1997 .

Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.

S. Holland, J. Hoofnagle, T. Liang, 2008, Gastroenterology.

Hepatitis C viral RNA in serum of patients with chronic non‐A, non‐B hepatitis: Detection by the polymerase chain reaction using multiple primer sets

J. Hoofnagle, A. D. Di Bisceglie, S. Feinstone, 1991, Hepatology.

Biliary atresia: Current concepts and research directions. Summary of a symposium

J. Hoofnagle, F. Suchy, R. Sokol, 1996, Hepatology.

A survey of liver transplantation from living adult donors in the United States.

Michael C. Richardson, J. Hoofnagle, J. Everhart, 2003, The New England journal of medicine.

Hepatic abnormalities in patients with chronic granulomatous disease

P. Choyke, S. Holland, J. Hoofnagle, 2007, Hepatology.

Drug‐induced liver injury: Mechanisms and test systems

G. Gores, J. Hoofnagle, D. Laskin, 2001, Hepatology.

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

M. Manns, I. Mackay, R. Chapman, 1999, Journal of hepatology.

Clinical and histologic features of azithromycin-induced liver injury.

Jiezhun Gu, R. Fontana, N. Chalasani, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical and Histological Features of Azithromycin-Induced Liver Injury

Jiezhun Gu, R. Fontana, N. Chalasani, 2015 .

Antibody to hepatitis B core antigen.

J. Hoofnagle, L. Barker, R. Gerety, 1975, The American journal of the medical sciences.

Immunology and the liver

F. Chisari, J. Hoofnagle, M. Gershwin, 1991, Hepatology.

Hepatitis A antigen particles in liver, bile, and stool of chimpanzees.

R. Purcell, J. Hoofnagle, L. Barker, 1976, The Journal of infectious diseases.

Hepatitis A and B virus markers in immune serum globulin

J. Hoofnagle, J. Waggoner, 1980 .

Hepatitis C: The clinical spectrum of disease

J. Hoofnagle, J H Hoofnagle, 1997, Hepatology.

Immune response in fulminant viral hepatitis, type B.

J. Hoofnagle, L. Barker, E. Tabor, 1976, Gastroenterology.

Jaundice Due to Bacterial Infection

J. Hoofnagle, L. Seeff, H. Zimmerman, 1979 .

Treatment of chronic type B hepatitis.

J. Hoofnagle, A. D. Di Bisceglie, 1989, Cancer detection and prevention.

Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis

S. Banks, J. Hoofnagle, M. Fried, 1993, Digestive Diseases and Sciences.

NIH conference. Hepatocellular carcinoma.

J. Hoofnagle, G. Dusheiko, A. D. Di Bisceglie, 1988, Annals of internal medicine.

Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs.

J. Hoofnagle, L. Barker, R. Gerety, 1974, Journal of immunology.

Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis.

J. Hoofnagle, G. Davis, M. Peters, 1986, Journal of interferon research.

Viral hepatitis and liver disease

J. Hoofnagle, G. Vyas, J. Dienstag, 1984 .

Helicobacter pylori in peptic ulcer disease.

Fred E. Silverstein, Nicholas J. Talley, David Forman, 1994, NIH consensus statement.

SERUM LEVELS OF GAMMA-AMINOBUTYRIC-ACID-LIKE ACTIVITY IN ACUTE AND CHRONIC HEPATOCELLULAR DISEASE

J. Hoofnagle, P. Ferenci, G. Kleinberger, 1983, The Lancet.

Management of hepatitis B: 2000--summary of a workshop.

A. Lok, J. Hoofnagle, A. Lok, 2001, Gastroenterology.

THE TREATMENT OF CHRONIC VIRAL HEPATITIS

J. Hoofnagle, Bisceglic A.M.D., 1997 .

Hepatitis B

J. Hoofnagle, 2005, Hepatology.

Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.

J. Hoofnagle, L. Seeff, G. Dusheiko, 1981, Annals of internal medicine.

Management of hepatitis B: Summary of a clinical research workshop

J. Hoofnagle, T. Liang, A. Lok, 2007, Hepatology.

Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.

J. Hoofnagle, S. Straus, D. Lau, 1998, The Journal of infectious diseases.

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1993, Gastroenterology.

Pilot study of recombinant human α-interferon for chronic type B hepatitis

J. Hoofnagle, G. Davis, Z. Goodman, 1986 .

Long-term remission of chronic hepatitis B after alpha-interferon therapy.

J. Hoofnagle, J. Everhart, B. Baker, 1991, Annals of internal medicine.

Reactivation of chronic hepatitis B virus infection.

J. Hoofnagle, G. Davis, 1987, Gastroenterology.

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

J. Hoofnagle, G. Dusheiko, R. Young, 1982, Annals of internal medicine.

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.

J. Hoofnagle, D. Kleiner, P. Schmid, 1997, Gastroenterology.

Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.

J. Hoofnagle, G. Minuk, G. Dusheiko, 1984, Gastroenterology.

Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay.

J. Hoofnagle, L. Barker, R. Gerety, 1977, Gastroenterology.

Interferon in viral hepatitis: Role in pathogenesis and treatment

J. Hoofnagle, G. Davis, 1986, Hepatology.

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.

J. Hoofnagle, D. Jones, M. Peters, 1986, The New England journal of medicine.

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

R. Wiesner, J. Hoofnagle, J. Everhart, 1997, Gastroenterology.

Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B

J. Hoofnagle, D. Kleiner, M. Ghany, 2012, Alimentary pharmacology & therapeutics.

Hepatitis B--preventable and now treatable.

J. Hoofnagle, Jay H Hoofnagle, 2006, The New England journal of medicine.

Randomized Controlled Trial of Adenine Arabinoside Monophosphate for Chronic Type B Hepatitis

J. Hoofnagle, G. Minuk, G. Dusheiko, 1984 .

Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B

J. Hoofnagle, A. D. Di Bisceglie, J. Waggoner, 1993, Hepatology.

Combination therapy of hepatitis B

J. Hoofnagle, E. Doo, 2000, Gut.

Therapy of chronic hepatitis B with a 6-month course of ribavirin.

S. Banks, J. Hoofnagle, M. Swain, 1994, Journal of hepatology.

National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C

Eugene R. Schiff, William H. Hall, W. H. Hall, 1997, Hepatology.

A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.

J. Hoofnagle, N. Bergasa, B. Baker, 1993, The American journal of gastroenterology.

New therapies for chronic hepatitis B

J. Hoofnagle, D. Lau, 1997, Journal of viral hepatitis.

Chronic viral hepatitis--benefits of current therapies.

J. Hoofnagle, D. Lau, 1996, The New England journal of medicine.

Relation of the hepatitis B virus carrier state to hepatocellular carcinoma

J. Hoofnagle, D. Shafritz, H. Popper, 1987, Hepatology.

Treatment of chronic type B hepatitis with multiple ten‐day courses of adenine arabinoside monophosphate

J. Hoofnagle, G. Davis, S. Straus, 1985, Journal of medical virology.

A pilot study of 2′,3′‐dideoxyinosine for the treatment of chronic hepatitis B

J. Hoofnagle, H. Mitsuya, S. Broder, 1992, Hepatology.

Predictors of patient and graft survival following liver transplantation for hepatitis C

R. Wiesner, J. Hoofnagle, K. Detre, 1998, Hepatology.

Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee

J. Hoofnagle, L. Barker, T. Michalak, 1978 .

Randomized Controlled Trial of a Four Month Course of Recombinant Human Alpha Interferon in Patients with Chronic Type B Hepatitis

J. Hoofnagle, Yikyung Park, D. Jones, 1987 .

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.

J. Hoofnagle, G. Davis, Z. Goodman, 1986, Gastroenterology.

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

S. Banks, J. Hoofnagle, Z. Goodman, 1989, The New England journal of medicine.

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.

B. McMahon, J. Hoofnagle, A. Parkinson, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.

R. Purcell, J. Hoofnagle, S. Kaneko, 1990, Gastroenterology.

Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.

J. Hoofnagle, G. Davis, M. Peters, 1986, Journal of immunology.

Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters.

J. Hoofnagle, A. D. Di Bisceglie, 1990, American Journal of Gastroenterology.

The interferon system in acute and chronic viral hepatitis.

J. Hoofnagle, G. Davis, J. Dooley, 1986, Progress in liver diseases.

Treatment of chronic type C hepatitis with alpha interferon.

J. Hoofnagle, A. D. Di Bisceglie, 1989, Seminars in liver disease (Print).

Chronic hepatitis B.

J. Hoofnagle, 1990, The New England journal of medicine.

Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.

J. Hoofnagle, 1986, Journal of hepatology.

Chronic type B hepatitis.

J. Hoofnagle, 1983, Gastroenterology.

Chronic type B hepatitis: clinical course.

J. Hoofnagle, G. Davis, R. Hanson, 1983, Progress in clinical and biological research.

Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg

J. Hoofnagle, A. Mangia, Y. Chung, 1996, Digestive Diseases and Sciences.

Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

J. Hoofnagle, T. Liang, R. Loomba, 2008, Annals of Internal Medicine.

Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.

J. Hoofnagle, A. L. Williams, A. Williams, 1988, Gastroenterology.

Spontaneous reactivation of chronic hepatitis B virus infection.

J. Hoofnagle, G. Davis, J. Waggoner, 1984, Gastroenterology.

10‐year follow‐up after interferon‐α therapy for chronic hepatitis C

J. Hoofnagle, D. Kleiner, M. Ghany, 1998 .

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

J. Hoofnagle, D. Kleiner, M. Ghany, 1998, Hepatology.

Ribavirin improves early responses to peginterferon through improved interferon signaling.

J. Hoofnagle, A. Neumann, T. Liang, 2010, Gastroenterology.

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 2006, Gastroenterology.

Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop

R. Fontana, J. Serrano, R. Andrade, 2010, Hepatology.

Renal tubular dysfunction during long‐term adefovir or tenofovir therapy in chronic hepatitis B

J. Hoofnagle, D. Kleiner, M. Ghany, 2012, Alimentary pharmacology & therapeutics.

Gallstones and laparoscopic cholecystectomy

John V. White, W. H. Hall, W. R. Foster, 1993, Surgical Endoscopy.

Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee.

J. Hoofnagle, L. Barker, T. Michalak, 1978, Gastroenterology.

Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study

J. Hoofnagle, E. Jones, S. Straus, 1985, Journal of medical virology.

Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers.

J. Hoofnagle, J. Kremastinou, G. Papaevangelou, 1974, Lancet.

Determination of hepatitis B phenotype using biochemical and serological markers

William M. Lee, R. Fontana, A. Lok, 2017, Journal of viral hepatitis.

Hepatitis B virus replication within the human spleen

J. Hoofnagle, A. D. Di Bisceglie, 1990, Journal of clinical microbiology.

Antibody to hepatitis B surface antigen in nonprimate animal species

J. Hoofnagle, P. Ferenci, D. Schafer, 1983 .

A rapid immunochromatographic assay for hepatitis B virus screening

J. Hoofnagle, S. Lemon, M. Ghany, 2003, Journal of viral hepatitis.

Antiviral treatment of chronic type B hepatitis.

J. Hoofnagle, 1987, Annals of internal medicine.

Acute type A hepatitis during chronic hepatitis B virus infection: Association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon

J. Hoofnagle, G. Davis, J. Waggoner, 1984, Journal of medical virology.

A pilot study of ribavirin therapy for chronic hepatitis C

J. Hoofnagle, N. Bergasa, M. Swain, 1992, Hepatology.

High levels of viral replication during acute hepatitis B infection predict progression to chronicity

J. Hoofnagle, A. D. Di Bisceglie, J. Waggoner, 1994, Journal of medical virology.

Viral kinetics in hepatitis C

J. Hoofnagle, G. Lutchman, 2003, Hepatology.

Therapy of Hepatitis C

J. Hoofnagle, M. Fried, J. Hoofnagle, 1995, Seminars in liver disease.

Posttransfusion hepatitis B

J. Hoofnagle, 1990, Transfusion.

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.

E. Schiff, G. Beebe, J. Hoofnagle, 1987, The New England journal of medicine.

Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis.

R. Purcell, R. Miller, J. Hoofnagle, 1990, Gastroenterology.

Challenges in therapy of chronic hepatitis B.

J. Hoofnagle, 2003, Journal of hepatology.

Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.

J. Hoofnagle, T. Liang, M. Ghany, 2007, Gastroenterology.

Type B hepatitis in Iran.

J. Hoofnagle, M. Tabarestani, A. Afkari, 1977, Acta medica Iranica.

Acute liver failure: Summary of a workshop

William M. Lee, J. Hoofnagle, S. Nyberg, 2007, Hepatology.

Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.

J. Hoofnagle, M. Sjogren, 1985, Gastroenterology.

Serologic Markers of Hepatitis B Virus Infection

J. Hoofnagle, J. Hoofnagle, D. Schafer, 1986, Annual review of medicine.

Hepatocellular carcinoma: summary and recommendations.

J. Hoofnagle, 2004, Gastroenterology.

Management of post-transfusion hepatitis.

J. Hoofnagle, A. D. Di Bisceglie, M. Lisker‐Melman, 1988, Transfusion medicine reviews.

Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

J. Hoofnagle, T. Liang, L. Seeff, 2000, Annals of Internal Medicine.

Living donor liver transplantation: Summary of a conference at The National Institutes of Health

Charles M. Miller, J. Hoofnagle, G. Everson, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatitis B Core Antigen: Immunology and Electron Microscopy

J. Hoofnagle, L. Barker, J. Almeida, 1974, Journal of virology.

The treatment of chronic viral hepatitis.

J. Hoofnagle, A. D. Di Bisceglie, 1997, The New England journal of medicine.

Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.

Jiezhun Gu, S. Emerson, R. Purcell, 2011, Gastroenterology.

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

H. Conjeevaram, J. Hoofnagle, C. Yurdaydın, 1995, Annals of internal medicine.

Primary sclerosing cholangitis: Summary of a workshop

G. Gores, J. Hoofnagle, N. LaRusso, 2006, Hepatology.

Therapy of chronic delta hepatitis with interferon alfa-2b.

J. Hoofnagle, N. Bergasa, B. Baker, 1990, Journal of hepatology.

Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis

J. Hoofnagle, M. Battegay, A. Bisceglie, 1994, Digestive Diseases and Sciences.

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy.

J. Hoofnagle, A. Bisceglie, D. Kleiner, 1999, Gastroenterology.

Type D (delta) hepatitis.

J. Hoofnagle, 1989, JAMA.

Delta Hepatitis and the Hepatitis Delta Virus

J. Hoofnagle, 1989 .

Effect of interferon-alpha on immunoglobulin synthesis by human B cells.

J. Hoofnagle, M. Peters, A. Zheleznyak, 1986, Journal of immunology.

Natural history of chronic type B hepatitis.

J. Hoofnagle, L. Seeff, 1982, Progress in liver diseases.

The disposition of 6‐deoxyacyclovir, a xanthine oxidase‐activated prodrug of acyclovir, in the isolated perfused rat liver

J. Hoofnagle, D. Jones, E. Jones, 1987, Hepatology.

Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection.

J. Hoofnagle, R. Sherertz, E. Spindel, 1983, The New England journal of medicine.

Hepatitis B in children. II. Study of children born to chronic HBsAg carrier mothers.

J. Hoofnagle, J. Drouet, P. Giraud, 1978, The Journal of pediatrics.

Studies of Donors Who Transmit Posttransfusion Hepatitis

Laura H. Smallwood, J. Hoofnagle, L. Barker, 1979, Transfusion.

Current Concepts Hepatitis E

R. Purcell, J. Hoofnagle, K. Nelson, 2012 .

Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.

J. Hoofnagle, A. D. Di Bisceglie, V. Rustgi, 1989, Annals of internal medicine.

Hepatic inclusions during interferon therapy in chronic viral hepatitis

J. Hoofnagle, Z. Schaff, P. Grimley, 1986, Hepatology.

Peginterferon and ribavirin for chronic hepatitis C.

J. Hoofnagle, L. Seeff, 2006, The New England journal of medicine.

Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen

R. Purcell, J. Hoofnagle, S. Kaneko, 1990, Gastroenterologia Japonica.

Race, insulin resistance and hepatic steatosis in chronic hepatitis C

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 2007, Hepatology.

Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?

J. Hoofnagle, T. Liang, B. Rehermann, 2014, The Journal of infectious diseases.

Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C

J. Hoofnagle, J. Everhart, M. Ghany, 2002, Hepatology.

Prolonged therapy of chronic hepatitis C with ribavirin

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 1996, Journal of viral hepatitis.

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.

J. Hoofnagle, C. Howell, S. Belle, 2009, The Journal of infectious diseases.

A Framework for Management of Hepatitis C in Prisons

H. Margolis, J. Hoofnagle, A. Spaulding, 2006, Annals of Internal Medicine.

Drug-Induced Liver Injury - Types and Phenotypes.

E. Björnsson, J. Hoofnagle, Jay H Hoofnagle, 2019, The New England journal of medicine.

Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis

J. Hoofnagle, M. Battegay, R. Sallie, 1994, Journal of medical virology.

Racial differences in responses to therapy with interferon in chronic hepatitis C

William M. Lee, J. Hoofnagle, K. Reddy, 1999, Hepatology.

Patient‐reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross‐sectional analysis

R. Fontana, J. Hoofnagle, A. Wahed, 2020, Alimentary pharmacology & therapeutics.

Course and outcome of hepatitis C

J. Hoofnagle, 2002 .

Optimal therapy of hepatitis C

J. Hoofnagle, A. D. Di Bisceglie, 2002 .

The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.

J. Hoofnagle, L. Barker, A. Notkins, 1975, Clinical and experimental immunology.

Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children.

J. Hoofnagle, L. Barker, J. Markenson, 1974, The Journal of pediatrics.

TRANSPLACENTAL TRANSMISSION OF HEPATITIS-B VIRUS BY SYMPTOM-FREE CHRONIC CARRIER MOTHERS

J. Hoofnagle, J. Kremastinou, G. Papaevangelou, 1975 .

Toward universal vaccination against hepatitis B virus.

J. Hoofnagle, 1989, The New England journal of medicine.

Hepatitis B surface antigen (HBS Ag) subtypes and indices of clinical disease.

J. Hoofnagle, L. Barker, R. Gerety, 1975, Gastroenterology.

Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.

J. Hoofnagle, W. Szmuness, A. Prince, 1974, Lancet.

Viral Hepatitis During Pregnancy

J. Hoofnagle, V. Rustgi, 1987, Seminars in liver disease.

Serological tests for non-A, non-B hepatitis: controversy.

J. Hoofnagle, S. Feinstone, 2008, Liver.

Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections.

W. Bancroft, J. Hoofnagle, S. Lemon, 1986, Gastroenterology.

Geographic distribution and genetic variability of hepatitis delta virus genotype I.

J. Hoofnagle, A. Bisceglie, J. Casey, 1997, Virology.

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

Jiezhun Gu, H. Barnhart, R. Fontana, 2017, Hepatology.

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease

Richard J. Thompson, O. Cummings, J. Hoofnagle, 2022, Hepatology.

Liver injury from cyclosporine A

J. Hoofnagle, R. Nussenblatt, A. Palestine, 1990, Digestive Diseases and Sciences.

Noninvasive markers for staging fibrosis in chronic delta hepatitis

J. Hoofnagle, D. Kleiner, C. Koh, 2017, Alimentary pharmacology & therapeutics.

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

J. Hoofnagle, J. Everhart, D. Kleiner, 2003, Hepatology.

Thrombocytopenia during interferon alfa therapy.

J. Hoofnagle, 1991, JAMA.

Hepatitis B Virus and Hepatitis B Surface Antigen in Human Albumin Products

J. Hoofnagle, L. Barker, J. Thiel, 1976, Transfusion.

Evaluation of hepatitis B antigen testing in federally licensed blood banks in the United States.

J. Hoofnagle, L. Barker, R. Gerety, 1975, American journal of clinical pathology.

Type A and Type B Hepatitis

J. Hoofnagle, 1983 .

Important Factors in Reliable Determination of Hepatitis C Virus Genotype by Use of the 5′ Untranslated Region

J. Hoofnagle, C. Koh, T. Heller, 2013, Journal of Clinical Microbiology.

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

J. Hoofnagle, J. Feld, Jay H. Hoofnagle, 2005, Nature.

Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis

R. Fontana, J. Hoofnagle, E. Phillips, 2019, Hepatology International.

Long‐term therapy of chronic delta hepatitis with peginterferon alfa

J. Hoofnagle, T. Liang, J. Albrecht, 2014, Alimentary pharmacology & therapeutics.

Virus Genotype using the 5' Untranslated Region

J. Hoofnagle, C. Koh, K. Hara, 2013 .

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection

J. Hoofnagle, D. Kleiner, M. Ghany, 2006, Hepatology.

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.

E. C. Walker, D. Alling, J. Hoofnagle, 1992, Gastroenterology.

Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon‐alpha therapy via mathematical modeling

Peter Schmid, Harel Dahari, Jeremie Guedj, 2014, Hepatology.

Molecular medicine and hemochromatosis: at the crossroads.

J. Hoofnagle, B. Bacon, P. Adams, 1999, Gastroenterology.

Cell-mediated immunity to hepatitis B surface antigen in man.

R. Purcell, J. Hoofnagle, G. Minuk, 1984, Clinical and experimental immunology.

Pruritus as a Presenting Symptom of Chronic Hepatitis C

J. Hoofnagle, D. Kleiner, Z. Goodman, 1998, Digestive Diseases and Sciences.

A Controlled Trial of Naloxone Infusions for the Pruritus of Chronic Cholestasis

D. Alling, J. Hoofnagle, T. Talbot, 1992 .

Effects of antiviral therapy on the cellular immune response in acute hepatitis C

J. Hoofnagle, T. Liang, B. Rehermann, 2004, Hepatology.

Idiosyncratic Drug Induced Liver Injury in African–Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians

Jiezhun Gu, H. Barnhart, R. Fontana, 2017, The American Journal of Gastroenterology.

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

J. Hoofnagle, T. Liang, D. Kleiner, 2003, Gastroenterology.

Jaundice due to bacterial infection.

J. Hoofnagle, L. Seeff, H. Zimmerman, 1979, Gastroenterology.

S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.

R. El-Diwany, J. Hoofnagle, T. Liang, 2011, Gastroenterology.

Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors

Jiezhun Gu, H. Barnhart, R. Fontana, 2019, Alimentary pharmacology & therapeutics.

Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy

J. Hoofnagle, D. Kleiner, M. Ghany, 2013, Alimentary pharmacology & therapeutics.

Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.

J. Hoofnagle, A. Wahed, Z. Jiang, 2012, Journal of hepatology.

Weight Cycling-Reply

J. Hoofnagle, S. Yanovski, 1995 .

Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-α therapy

H. Conjeevaram, J. Hoofnagle, A. Soza, 2003 .

Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) community.

J. Hoofnagle, L. Nicolle, G. Minuk, 1986, Scandinavian journal of infectious diseases.

Antimicrobials and anti-epileptics are the leading causes of idiosyncratic drug induced liver injury in american children.

Jiezhun Gu, H. Barnhart, R. Fontana, 2019, Journal of pediatric gastroenterology and nutrition.

Seizures during alpha interferon therapy.

J. Hoofnagle, A. Bisceglie, A. D. Di Bisceglie, 1996, Journal of hepatology.

An Epidemiologic Investigation of a Case of Acute Hepatitis E

R. Purcell, J. Hoofnagle, T. Liang, 2015, Journal of Clinical Microbiology.

Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies.

J. Hoofnagle, W. Szmuness, A. Prince, 1976, American journal of epidemiology.

Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience

J. Hoofnagle, T. Liang, D. Kleiner, 2017, Alimentary pharmacology & therapeutics.

Primary biliary cirrhosis clinical research single‐topic conference

E. Dickson, J. Hoofnagle, W. Maddrey, 1996, Hepatology.

Identification and Characterization of Fenofibrate-Induced Liver Injury

H. Barnhart, R. Fontana, N. Chalasani, 2017, Digestive Diseases and Sciences.

Death and liver transplantation within 2 years of onset of drug‐induced liver injury

H. Barnhart, R. Fontana, N. Chalasani, 2017, Hepatology.

Features of Autoimmune Hepatitis in Patients With Drug‐induced Liver Injury

N. Chalasani, J. Hoofnagle, A. Kosinski, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver injury from nonsteroidal anti‐inflammatory drugs in the United States

R. Fontana, J. Hoofnagle, A. Kosinski, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug‐Induced Liver Injury Network (DILIN)

H. Barnhart, J. Talwalkar, R. Fontana, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study

Jiezhun Gu, R. Fontana, H. Bonkovsky, 2021, Journal of Hepatology.

Drug‐induced liver injury network (DILIN)

J. Hoofnagle, Jay H Hoofnagle, 2004, Hepatology.

Low‐ and standard‐dose peginterferon alfa‐2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response

J. Hoofnagle, A. Neumann, M. Ghany, 2010, Alimentary pharmacology & therapeutics.

Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study

R. Fontana, J. Hoofnagle, I. Khan, 2016, Drug Safety.

Fatigue and serum carnitine levels in chronic liver disease

J. Hoofnagle, S. Sarkar, 2011, Alimentary pharmacology & therapeutics.

Increased waiting time for liver transplantation results in higher mortality.

R. Wiesner, J. Hoofnagle, K. Detre, 1997, Transplantation.

Vitamin D receptor (VDR) polymorphisms and bone mineral density (BMD) in primary biliary cirrhosis

H. Conjeevaram, J. Hoofnagle, D. Herion, 1995 .

Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease

Kathryn J Fowler, O. Cummings, C. Sirlin, 2018, The Journal of pediatrics.

Prevalence of antibody to hepatitis A virus in a Canadian Inuit community.

J. Hoofnagle, L. Nicolle, G. Minuk, 1982, Canadian Medical Association journal.

Evaluation of the patient with hepatitis B

J. Hoofnagle, Y. Rotman, T. Brown, 2009, Hepatology.

Dieting and the development of eating disorders in overweight and obese adults.

L. Epstein, T. Wadden, R. Wing, 2000, Archives of internal medicine.

Biliary Atresia Research Consortium (BARC)

J. Hoofnagle, 2004, Hepatology.

Chronic non-A, non-B hepatitis.

J. Hoofnagle, H. Alter, 1985, Progress in clinical and biological research.

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

H. Conjeevaram, J. Hoofnagle, J. Everhart, 1995, Hepatology.

Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.

J. Hoofnagle, D. Kleiner, N. Bergasa, 1996, The American journal of gastroenterology.

Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis

J. Hoofnagle, T. Liang, D. Kleiner, 2022, The American journal of gastroenterology.

NIH conference: Primary biliary cirrhosis: a model autoimmune disease.

J. Hoofnagle, S. James, E. Jones, 1983, Annals of internal medicine.

Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland.

J. Hoofnagle, T. Beresford, J. Lake, 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Antibody to the Hepatitis B Virus- Associated Delta-Agent in Immune Serum Globulins

J. Hoofnagle, L. Seeff, A. Ponzetto, 1984 .

Non-A, maybe-B hepatitis.

J. Hoofnagle, S. Feinstone, 1984, The New England journal of medicine.

Serologic Evidence for Hepatitis B Virus Infection in Patients with Hemophilia B

J. Hoofnagle, D. Aronson, H. Roberts, 1975, Thrombosis and Haemostasis.

Current concepts in viral hepatitis.

J. Hoofnagle, 1979, Arquivos de gastroenterologia.

Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury

H. Barnhart, R. Fontana, N. Chalasani, 2019, Digestive Diseases and Sciences.

An outbreak of type B hepatitis associated with transfusion of plasma protein fraction.

J. Hoofnagle, L. Barker, J. Maynard, 1976, American journal of epidemiology.

Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon

J. Hoofnagle, A. D. Di Bisceglie, V. Rustgi, 1990, Hepatology.

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

J. Hoofnagle, L. Seeff, L B Seeff, 2006, Oncogene.

Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.

J. Hoofnagle, T. Liang, D. Kleiner, 2013, Clinical Gastroenterology and Hepatology.

Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis

Christopher J. N. Kigongo, N. Chalasani, J. Hoofnagle, 2018, Alimentary pharmacology & therapeutics.

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis

J. Hoofnagle, T. Liang, D. Kleiner, 2007, Hepatology.

Liver Injury Associated with Turmeric-a Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN].

R. Fontana, J. Hoofnagle, D. Kleiner, 2022, The American journal of medicine.

Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity.

William M. Lee, Jiezhun Gu, J. Talwalkar, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection

R. Bilonick, R. Fontana, J. Hoofnagle, 2006, Hepatology.

Very Low-Calorie Diets for Obesity-Reply

J. Hoofnagle, S. Yanovski, 1994 .

HLA‐B*35:01 and Green Tea–Induced Liver Injury

Jiezhun Gu, H. Barnhart, R. Fontana, 2020, Hepatology.

Morphologic Features of the Liver in Abetalipoproteinemia

K. Ishak, J. Hoofnagle, R. Gregg, 1984, Hepatology.

Chapter 40 – LiverTox: A Website on Drug-Induced Liver Injury

J. Hoofnagle, 2013 .

Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis.

J. Hoofnagle, M. Frank, G. Minuk, 1985, Gastroenterology.

Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.

J. Hoofnagle, S. Belle, A. Wahed, 2009, Gastroenterology.

Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

R. Fontana, J. Hoofnagle, P. Bacchetti, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C

A. Perelson, J. Hoofnagle, H. Dahari, 2013, Gut.

A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH

Christopher J. N. Kigongo, Kathryn J Fowler, O. Cummings, 2019, Hepatology communications.

Hepatitis E

R. Purcell, J. Hoofnagle, K. Nelson, 2013, Water and Sanitation for the 21st Century: Health and Microbiological Aspects of Excreta and Wastewater Management (Global Water Pathogen Project).

Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

M. Manns, M. Buti, D. Vergani, 2023, Journal of hepatology.

Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype.

J. Hoofnagle, T. Liang, Y. Rotman, 2013, Journal of hepatology.

A step forward in therapy for hepatitis C.

J. Hoofnagle, Jay H Hoofnagle, 2009, The New England journal of medicine.

Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.

Milton W. Taylor, J. Hoofnagle, C. Howell, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)

Geoffrey S Johnson, B. Reeve, R. Fontana, 2016, Digestive Diseases and Sciences.

Primary hepatocellular carcinoma and hepatitis B virus infection in korea

J. Hoofnagle, G. Minuk, D. Park, 1983, Journal of medical virology.

Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis

H. Barnhart, R. Fontana, H. Bonkovsky, 2012, Annals of Internal Medicine.

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.

H. Conjeevaram, J. Hoofnagle, J. Everhart, 2011, Gastroenterology.

Hepatitis C in African Americans: summary of a workshop.

J. Hoofnagle, C. Howell, L. Jeffers, 2000, Gastroenterology.

IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine.

R. Purcell, J. Hoofnagle, G. Minuk, 1983, The Journal of infectious diseases.

Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis.

J. Hoofnagle, R. Costello, A. D. Di Bisceglie, 1990, American Journal of Gastroenterology.

Denying the wolf access to sheep's clothing.

J. Hoofnagle, T. Heller, 2003, The Journal of clinical investigation.

Serum hepatitis G virus RNA in patients with chronic viral hepatitis.

J. Hoofnagle, A. Marrone, H. Alter, 1997, The American journal of gastroenterology.

Hepatic decompensation during direct-acting antiviral therapy of chronic hepatitis C.

J. Hoofnagle, 2016, Journal of hepatology.

LP15 : Separate and combined effects of obeticholic acid and weight loss in nonalcoholic steatohepatitis (NASH)

N. Chalasani, J. Hoofnagle, N. Terrault, 2015 .

Chronic fatigue syndrome: Lack Of association with hepatitis C virus infection

J. Hoofnagle, A. Bisceglie, S. Straus, 1991, Journal of medical virology.

Statistical models for predicting a beneficial response to interferon‐α in patients with chronic hepatitis B

J. Hoofnagle, L. Comanor, J. Minor, 1998, Journal of viral hepatitis.

A revised electronic version of RUCAM for the diagnosis of DILI

Jiezhun Gu, E. Bjornsson, R. Fontana, 2022, Hepatology.

Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles

H. Barnhart, R. Fontana, J. Hoofnagle, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Mortality rate during interferon alfa‐ribavirin combination therapy of chronic hepatitis C

J. Hoofnagle, A. Soza, 2003, Hepatology.

Neonatal screening for biliary atresia

J. Hoofnagle, R. Sokol, 2006, Hepatology.

167 Herbal and Dietary Supplement Induced Hepatotoxicity in the U.S.

H. Barnhart, J. Talwalkar, R. Fontana, 2012 .

Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.

J. Hoofnagle, A. D. Di Bisceglie, M. Lotze, 1994, Journal of clinical gastroenterology.

Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database.

R. Wiesner, J. Hoofnagle, M. Lombardero, 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Long‐term lamivudine therapy in chronic hepatitis B

J. Hoofnagle, S. Lingala, M. Ghany, 2016, Alimentary pharmacology & therapeutics.

Acute Hepatitis B Virus Infection in North American Adults.

William M. Lee, J. Hoofnagle, A. Wahed, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B

J. Hoofnagle, A. D. Di Bisceglie, J. Waggoner, 1993, Hepatology.

Hepatitis virus infection in an isolated canadian inuit (Eskimo) population

J. Hoofnagle, L. Nicolle, G. Minuk, 1982, Journal of medical virology.

Genotypic analysis of hepatitis C virus in American patients

J. Hoofnagle, A. Bisceglie, R. Sallie, 1994 .

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

William M. Lee, Huiman X. Barnhart, Robert J. Fontana, 2015, Gastroenterology.

Antibody to Hepatitis B Core Antigen in Blood Donors with a History of Hepatitis

J. Hoofnagle, L. Barker, E. Tabor, 1981, Transfusion.

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 1995, The New England journal of medicine.

A Modern Therapy for an Ancient Disease.

J. Hoofnagle, 2022, The New England journal of medicine.

9 – VIRAL HEPATITIS

J. Hoofnagle, 1984 .

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

J. Berzofsky, C. Rice, A. Sette, 1995, Journal of virology.

Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

J. Hoofnagle, L. Barker, R. Gerety, 1974 .

Acute Exacerbation of Liver Interferon Alfa Therapy for Hepatitis C 1 Disease Chronic During

J. Hoofnagle, A. Bisceglie, M. Shindo, 1992 .

Recombinant human α-interferon: A promissory note in non-A, non-B chronic hepatitis

J. Hoofnagle, A. Bisceglie, 1987 .

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

P. Rosenthal, N. Chalasani, J. Hoofnagle, 2017 .

Hepatitis in patients with acute nonlymphocytic leukemia.

J. Hoofnagle, M. Gaffey, C. Schiffer, 1983, The American journal of medicine.

Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon‐α

J. Hoofnagle, A. McCullough, K. Mullen, 1994, Hepatology.

The Impact of Patient Age and Corticosteroids in Patients With Sulfonamide Hepatotoxicity

Jiezhun Gu, R. Fontana, H. Bonkovsky, 2023, The American journal of gastroenterology.

Erratum: Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C (Gastroenterology (2003) 124 (352-360))

J. Hoofnagle, T. Liang, D. Kleiner, 2003 .